Effects of flunixin, tolfenamic acid, R(-) and S(+) ketoprofen on the response of equine synoviocytes to lipopolysaccharide stimulation.

The research investigates the effects of four nonsteroidal anti-inflammatory drugs (NSAIDs) on inflammatory response parameters in equine synoviocytes stimulated by lipopolysaccharide. The study discovered that all four drugs influence the release of various inflammatory mediators, implicating implications for prolonged NSAID use in joint diseases.

Study Objective and Methodology

• The aim of this study was to evaluate the actions of four nonsteroidal anti-inflammatory drugs (NSAIDs) on the generation of numerous inflammatory markers in lipopolysaccharide (LPS)-triggered equine synoviocytes (joint-lining cells in horses).
• The NSAIDs studied were flunixin, tolfenamic acid, S(+)ketoprofen, and R(-)ketoprofen.
• The researchers primarily focused on how these drugs affect the release of beta-glucuronidase, tumor necrosis factor alpha, interleukin-6, interleukin-1, and prostaglandin E2, all of which play significant roles in inflammatory responses.

Findings

• In the presence of LPS, all four NSAIDs were found to suppress beta-glucuronidase release from the synoviocytes, with tolfenamic acid being the most effective.
• Among the two ketoprofen isomers, S(+)ketoprofen displayed the strongest inhibitory impact.
• Tolfenamic acid and flunixin dedicated a rise in interleukin-6 activity at the highest studied concentration, but not at lower amounts.
• Flunixin, tolfenamic acid, and S(+)ketoprofen exhibited a substantial concentration-dependent augmentation in the discharge of interleukin-1 induced by LPS.
• The creation of prostaglandin E2, which has anti-inflammatory properties, was significantly reduced by all four NSAIDs. Nevertheless, R(-)ketoprofen was only effective at the highest concentrations examined.

Implications

• These findings suggest that the prolonged use of NSAIDs for the treatment of joint diseases could enhance cartilage degeneration. This is because these drugs appear to alter the balance between interleukin-1, which promotes inflammation and tissue damage, and prostaglandin E2, which regulates interleukin-1 synthesis.
• Such results undeniably prompt a reevaluation of the potential repercussions of long-term NSAID use in the management of arthropathies, as increased cartilage degeneration could lead to worsened joint health.